Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis

Gaspar P, Kallemeijn WW, Strijland A, Scheij S, Van Eijk M, Aten J, Overkleeft HS, Balreira A, Zunke F, Schwake M, Miranda CS, et al. (2014)
The Journal of Lipid Research 55(1): 138-145.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Gaspar, Paulo; Kallemeijn, Wouter W.; Strijland, Anneke; Scheij, Saskia; Van Eijk, Marco; Aten, Jan; Overkleeft, Herman S.; Balreira, Andrea; Zunke, Friederike; Schwake, MichaelUniBi ; Miranda, Clara Sa; Aerts, Johannes M. F. G.
Alle
Abstract / Bemerkung
Lysosomal integral membrane protein-2 (LIMP2) mediates trafficking of glucocerebrosidase (GBA) to lysosomes. Deficiency of LIMP2 causes action myoclonus-renal failure syndrome (AMRF). LIMP2-deficient fibroblasts virtually lack GBA like the cells of patients with Gaucher disease (GD), a lysosomal storage disorder caused by mutations in the GBA gene. While GD is characterized by the presence of glucosylceramide-laden macrophages, AMRF patients do not show these. We studied the fate of GBA in relation to LIMP2 deficiency by employing recently designed activity-based probes labeling active GBA molecules. We demonstrate that GBA is almost absent in lysosomes of AMRF fibroblasts. However, white blood cells contain considerable amounts of residual enzyme. Consequently, AMRF patients do not acquire lipid-laden macrophages and do not show increased plasma levels of macrophage markers, such as chitotriosidase, in contrast to GD patients. We next investigated the consequences of LIMP2 deficiency with respect to plasma glycosphingolipid levels. Plasma glucosylceramide concentration was normal in the AMRF patients investigated as well as in LIMP2-deficient mice. However, a marked increase in the sphingoid base, glucosylsphingosine, was observed in AMRF patients and LIMP2-deficient mice. Our results suggest that combined measurements of chitotriosidase and glucosylsphingosine can be used for convenient differential laboratory diagnosis of GD and AMRF.
Stichworte
glucosylsphingosine; LIMP2/SCARB2; glucocerebrosidase; storage diseases; sphingolipids; scavenger receptors; macrophages/monocytes; Gaucher disease
Erscheinungsjahr
2014
Zeitschriftentitel
The Journal of Lipid Research
Band
55
Ausgabe
1
Seite(n)
138-145
ISSN
0022-2275
Page URI
https://pub.uni-bielefeld.de/record/2660866

Zitieren

Gaspar P, Kallemeijn WW, Strijland A, et al. Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis. The Journal of Lipid Research. 2014;55(1):138-145.
Gaspar, P., Kallemeijn, W. W., Strijland, A., Scheij, S., Van Eijk, M., Aten, J., Overkleeft, H. S., et al. (2014). Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis. The Journal of Lipid Research, 55(1), 138-145. doi:10.1194/jlr.M043802
Gaspar, P., Kallemeijn, W. W., Strijland, A., Scheij, S., Van Eijk, M., Aten, J., Overkleeft, H. S., Balreira, A., Zunke, F., Schwake, M., et al. (2014). Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis. The Journal of Lipid Research 55, 138-145.
Gaspar, P., et al., 2014. Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis. The Journal of Lipid Research, 55(1), p 138-145.
P. Gaspar, et al., “Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis”, The Journal of Lipid Research, vol. 55, 2014, pp. 138-145.
Gaspar, P., Kallemeijn, W.W., Strijland, A., Scheij, S., Van Eijk, M., Aten, J., Overkleeft, H.S., Balreira, A., Zunke, F., Schwake, M., Miranda, C.S., Aerts, J.M.F.G.: Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis. The Journal of Lipid Research. 55, 138-145 (2014).
Gaspar, Paulo, Kallemeijn, Wouter W., Strijland, Anneke, Scheij, Saskia, Van Eijk, Marco, Aten, Jan, Overkleeft, Herman S., Balreira, Andrea, Zunke, Friederike, Schwake, Michael, Miranda, Clara Sa, and Aerts, Johannes M. F. G. “Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis”. The Journal of Lipid Research 55.1 (2014): 138-145.

8 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Localization of active endogenous and exogenous β-glucocerebrosidase by correlative light-electron microscopy in human fibroblasts.
van Meel E, Bos E, van der Lienden MJC, Overkleeft HS, van Kasteren SI, Koster AJ, Aerts JMFG., Traffic 20(5), 2019
PMID: 30895685
Glycoprotein Non-Metastatic Protein B: An Emerging Biomarker for Lysosomal Dysfunction in Macrophages.
van der Lienden MJC, Gaspar P, Boot R, Aerts JMFG, van Eijk M., Int J Mol Sci 20(1), 2018
PMID: 30586924
Elevation of glycoprotein nonmetastatic melanoma protein B in type 1 Gaucher disease patients and mouse models.
Kramer G, Wegdam W, Donker-Koopman W, Ottenhoff R, Gaspar P, Verhoek M, Nelson J, Gabriel T, Kallemeijn W, Boot RG, Laman JD, Vissers JP, Cox T, Pavlova E, Moran MT, Aerts JM, van Eijk M., FEBS Open Bio 6(9), 2016
PMID: 27642553
Association Between Progranulin and Gaucher Disease.
Jian J, Zhao S, Tian QY, Liu H, Zhao Y, Chen WC, Grunig G, Torres PA, Wang BC, Zeng B, Pastores G, Tang W, Sun Y, Grabowski GA, Kong MX, Wang G, Chen Y, Liang F, Overkleeft HS, Saunders-Pullman R, Chan GL, Liu CJ., EBioMedicine 11(), 2016
PMID: 27515686
New Directions in Gaucher Disease.
Horowitz M, Elstein D, Zimran A, Goker-Alpan O., Hum Mutat 37(11), 2016
PMID: 27449603
Progranulin Recruits HSP70 to β-Glucocerebrosidase and Is Therapeutic Against Gaucher Disease.
Jian J, Tian QY, Hettinghouse A, Zhao S, Liu H, Wei J, Grunig G, Zhang W, Setchell KDR, Sun Y, Overkleeft HS, Chan GL, Liu CJ., EBioMedicine 13(), 2016
PMID: 27789271
Role of LIMP-2 in the intracellular trafficking of β-glucosidase in different human cellular models.
Malini E, Zampieri S, Deganuto M, Romanello M, Sechi A, Bembi B, Dardis A., FASEB J 29(9), 2015
PMID: 26018676
Lysosome sorting of β-glucocerebrosidase by LIMP-2 is targeted by the mannose 6-phosphate receptor.
Zhao Y, Ren J, Padilla-Parra S, Fry EE, Stuart DI., Nat Commun 5(), 2014
PMID: 25027712

34 References

Daten bereitgestellt von Europe PubMed Central.


Beutler E., Grabowski G.., 2001
The biology of the Gaucher cell: the cradle of human chitinases.
Bussink AP, van Eijk M, Renkema GH, Aerts JM, Boot RG., Int. Rev. Cytol. 252(), 2006
PMID: 16984816
Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.
Hollak CE, van Weely S, van Oers MH, Aerts JM., J. Clin. Invest. 93(3), 1994
PMID: 8132768
Substrate reduction therapy of glycosphingolipid storage disorders.
Aerts JM, Hollak CE, Boot RG, Groener JE, Maas M., J. Inherit. Metab. Dis. 29(2-3), 2006
PMID: 16763917
Plasma and metabolic abnormalities in Gaucher's disease.
Aerts JM, Hollak CE., Baillieres Clin. Haematol. 10(4), 1997
PMID: 9497858
Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response.
Dekker N, van Dussen L, Hollak CE, Overkleeft H, Scheij S, Ghauharali K, van Breemen MJ, Ferraz MJ, Groener JE, Maas M, Wijburg FA, Speijer D, Tylki-Szymanska A, Mistry PK, Boot RG, Aerts JM., Blood 118(16), 2011
PMID: 21868580
Efficient routing of glucocerebrosidase to lysosomes requires complex oligosaccharide chain formation.
Aerts JM, Brul S, Donker-Koopman WE, van Weely S, Murray GJ, Barranger JA, Tager JM, Schram AW., Biochem. Biophys. Res. Commun. 141(2), 1986
PMID: 2948505
Ultrasensitive in situ visualization of active glucocerebrosidase molecules.
Witte MD, Kallemeijn WW, Aten J, Li KY, Strijland A, Donker-Koopman WE, van den Nieuwendijk AM, Bleijlevens B, Kramer G, Florea BI, Hooibrink B, Hollak CE, Ottenhoff R, Boot RG, van der Marel GA, Overkleeft HS, Aerts JM., Nat. Chem. Biol. 6(12), 2010
PMID: 21079602
Activity-based profiling of retaining β-glucosidases: a comparative study.
Witte MD, Walvoort MT, Li KY, Kallemeijn WW, Donker-Koopman WE, Boot RG, Aerts JM, Codee JD, van der Marel GA, Overkleeft HS., Chembiochem 12(8), 2011
PMID: 21538758
Irreversible inhibitors and activity-based probes as research tools in chemical glycobiology.
Witte MD, van der Marel GA, Aerts JM, Overkleeft HS., Org. Biomol. Chem. 9(17), 2011
PMID: 21769371
Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies.
Aerts JM, Kallemeijn WW, Wegdam W, Joao Ferraz M, van Breemen MJ, Dekker N, Kramer G, Poorthuis BJ, Groener JE, Cox-Brinkman J, Rombach SM, Hollak CE, Linthorst GE, Witte MD, Gold H, van der Marel GA, Overkleeft HS, Boot RG., J. Inherit. Metab. Dis. 34(3), 2011
PMID: 21445610
Glucocerebrosidase, a lysosomal enzyme that does not undergo oligosaccharide phosphorylation.
Aerts JM, Schram AW, Strijland A, van Weely S, Jonsson LM, Tager JM, Sorrell SH, Ginns EI, Barranger JA, Murray GJ., Biochim. Biophys. Acta 964(3), 1988
PMID: 3349099
Mannose 6-phosphate-independent targeting of cathepsin D to lysosomes in HepG2 cells.
Rijnboutt S, Kal AJ, Geuze HJ, Aerts H, Strous GJ., J. Biol. Chem. 266(35), 1991
PMID: 1660878
Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function.
Saftig P, Klumperman J., Nat. Rev. Mol. Cell Biol. 10(9), 2009
PMID: 19672277
LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase.
Reczek D, Schwake M, Schroder J, Hughes H, Blanz J, Jin X, Brondyk W, Van Patten S, Edmunds T, Saftig P., Cell 131(4), 2007
PMID: 18022370
Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis.
Berkovic SF, Dibbens LM, Oshlack A, Silver JD, Katerelos M, Vears DF, Lullmann-Rauch R, Blanz J, Zhang KW, Stankovich J, Kalnins RM, Dowling JP, Andermann E, Andermann F, Faldini E, D'Hooge R, Vadlamudi L, Macdonell RA, Hodgson BL, Bayly MA, Savige J, Mulley JC, Smyth GK, Power DA, Saftig P, Bahlo M., Am. J. Hum. Genet. 82(3), 2008
PMID: 18308289
A nonsense mutation in the LIMP-2 gene associated with progressive myoclonic epilepsy and nephrotic syndrome.
Balreira A, Gaspar P, Caiola D, Chaves J, Beirao I, Lima JL, Azevedo JE, Miranda MC., Hum. Mol. Genet. 17(14), 2008
PMID: 18424452
Biochemical and molecular findings in a patient with myoclonic epilepsy due to a mistarget of the beta-glucosidase enzyme.
Dardis A, Filocamo M, Grossi S, Ciana G, Franceschetti S, Dominissini S, Rubboli G, Di Rocco M, Bembi B., Mol. Genet. Metab. 97(4), 2009
PMID: 19454373
Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2 mutations in isolated AMRF features.
Hopfner F, Schormair B, Knauf F, Berthele A, Tolle TR, Baron R, Maier C, Treede RD, Binder A, Sommer C, Maihofner C, Kunz W, Zimprich F, Heemann U, Pfeufer A, Nabauer M, Kaab S, Nowak B, Gieger C, Lichtner P, Trenkwalder C, Oexle K, Winkelmann J., BMC Neurol 11(), 2011
PMID: 22032306
SCARB2 mutations in progressive myoclonus epilepsy (PME) without renal failure.
Dibbens LM, Michelucci R, Gambardella A, Andermann F, Rubboli G, Bayly MA, Joensuu T, Vears DF, Franceschetti S, Canafoglia L, Wallace R, Bassuk AG, Power DA, Tassinari CA, Andermann E, Lehesjoki AE, Berkovic SF., Ann. Neurol. 66(4), 2009
PMID: 19847901
Clinical and neurophysiologic features of progressive myoclonus epilepsy without renal failure caused by SCARB2 mutations.
Rubboli G, Franceschetti S, Berkovic SF, Canafoglia L, Gambardella A, Dibbens LM, Riguzzi P, Campieri C, Magaudda A, Tassinari CA, Michelucci R., Epilepsia 52(12), 2011
PMID: 22050460
Progressive myoclonus epilepsy with nephropathy C1q due to SCARB2/LIMP-2 deficiency: clinical report of two siblings.
Chaves J, Beirao I, Balreira A, Gaspar P, Caiola D, Sa-Miranda MC, Lima JL., Seizure 20(9), 2011
PMID: 21782476
A procedure for the rapid purification in high yield of human glucocerebrosidase using immunoaffinity chromatography with monoclonal antibodies.
Aerts JM, Donker-Koopman WE, Murray GJ, Barranger JA, Tager JM, Schram AW., Anal. Biochem. 154(2), 1986
PMID: 3728974
Enhanced lysosomal acidification leads to increased chloroquine accumulation in CHO cells expressing the pfmdr1 gene.
van Es HH, Renkema H, Aerts H, Schurr E., Mol. Biochem. Parasitol. 68(2), 1994
PMID: 7739667
HPLC for simultaneous quantification of total ceramide, glucosylceramide, and ceramide trihexoside concentrations in plasma.
Groener JE, Poorthuis BJ, Kuiper S, Helmond MT, Hollak CE, Aerts JM., Clin. Chem. 53(4), 2007
PMID: 17332150
Novel activity-based probes for broad-spectrum profiling of retaining β-exoglucosidases in situ and in vivo.
Kallemeijn WW, Li KY, Witte MD, Marques AR, Aten J, Scheij S, Jiang J, Willems LI, Voorn-Brouwer TM, van Roomen CP, Ottenhoff R, Boot RG, van den Elst H, Walvoort MT, Florea BI, Codee JD, van der Marel GA, Aerts JM, Overkleeft HS., Angew. Chem. Int. Ed. Engl. 51(50), 2012
PMID: 23139194
The cytosolic β-glucosidase GBA3 does not influence type 1 Gaucher disease manifestation.
Dekker N, Voorn-Brouwer T, Verhoek M, Wennekes T, Narayan RS, Speijer D, Hollak CE, Overkleeft HS, Boot RG, Aerts JM., Blood Cells Mol. Dis. 46(1), 2010
PMID: 20728381
The occurrence of two immunologically distinguishable beta-glucocerebrosidases in human spleen.
Aerts JM, Donker-Koopman WE, van der Vliet MK, Jonsson LM, Ginns EI, Murray GJ, Barranger JA, Tager JM, Schram AW., Eur. J. Biochem. 150(3), 1985
PMID: 4018098
Function of oligosaccharide modification in glucocerebrosidase, a membrane-associated lysosomal hydrolase.
Van Weely S, Aerts JM, Van Leeuwen MB, Heikoop JC, Donker-Koopman WE, Barranger JA, Tager JM, Schram AW., Eur. J. Biochem. 191(3), 1990
PMID: 2143986
Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages.
Boven LA, van Meurs M, Boot RG, Mehta A, Boon L, Aerts JM, Laman JD., Am. J. Clin. Pathol. 122(3), 2004
PMID: 15362365
Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease.
Deegan PB, Moran MT, McFarlane I, Schofield JP, Boot RG, Aerts JM, Cox TM., Blood Cells Mol. Dis. 35(2), 2005
PMID: 16125420
The synthetic pathway for glucosylsphingosine in cultured fibroblasts.
Yamaguchi Y, Sasagasako N, Goto I, Kobayashi T., J. Biochem. 116(3), 1994
PMID: 7852294

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 24212238
PubMed | Europe PMC

Suchen in

Google Scholar